Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 12 | 13 | +1 |
| Shares | 1.01M | 1.08M | +63.7K (+6.3%) |
| Value | $5.97M | $7.87M | +$1.90M (+31.9%) |
New holders (3)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 3,229 | $24.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,052 | $8.00K | 0.00% |
| Newbridge Financial Services Group, Inc. | 400 | $3.00K | 0.00% |
Sold out (2)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Morgan Stanley | 500 | $3.00K |
| Bank of America Corp | 28 | $0 |